I'm surprised the pps is still holding in the .20 range. After the r/s, the pps was hovering around .40+/- and the big up-tick from there seemed to be the shortening of time for news to be released about the AGENDA trial results, not near as much the Testaxel expectations which are still a bit in the future. Had these results been released at the .40 range, I think the current pps would be much lower, possibly .10 or less right now. I think that after the dust settles, so will the pps, down to that range(below .10)... Only my opinion, but AGENDA was the propulsion lately and Testaxel is still too far out to keep the pps up. Of course todays news sucks, but it also seems that some are looking for comfort in Gentas other future prospects which they hadn't really called for before today(some people). What happens now to financing for Testaxel? They were banking on Genasense for bringing in plenty to not have to worry about it. Looks to me like it will be more of the same(dillution and r/s,s) on the backs of common holders to once again keep Genta afloat. Just doesn't look so good right now and the pps seems unsustainable for any period of time. JMO
